Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1897–1920 of 8,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Sickle Cell Anemia
Interventions: Not listed
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 8 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Covid19
Interventions: CVXGA1 low dose, CVXGA1 high dose; Biological
Lead sponsor: CyanVac LLC; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: Bardstown, Kentucky • Rochester, New York • Cincinnati, Ohio + 1 more

Conditions: Lymphoma
Interventions: carmustine, cyclophosphamide, etoposide, autologous hematopoietic stem cell transplantation, peripheral blood stem cell transplantation, total-body irradiation, G-CSF; Drug · Procedure · Radiation
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 16 Years to 59 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2011
U.S. locations: 2
States / cities: Phoenix, Arizona • Duarte, California

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
Interventions: Ketorolac, Placebo; Drug · Other
Lead sponsor: New Mexico Cancer Research Alliance; Other
Eligibility: 18 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Sedentary Behavior, Cardiovascular Risk Factor, Mental Stress, Cognitive Change, Cerebrovascular Insufficiency
Interventions: Mental Arithmetic Test; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 35 Years to 59 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Amyloidosis, Hereditary, Amyloidosis Cardiac, Amyloidosis, Familial, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy, Transthyretin Gene Mutation
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 30 Years to 80 Years
Enrollment: 500 participants
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: New York, New York • Cleveland, Ohio • Dallas, Texas

Conditions: Epilepsy
Interventions: Not listed
Lead sponsor: Swedish Medical Center; Other
Eligibility: 10 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Depressive Disorder, Anxiety, Adolescent
Interventions: Breathing Intervention; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 17 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Albert Lea, Minnesota • Eau Claire, Wisconsin

Conditions: Cystic Fibrosis
Interventions: Not listed
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 12 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2024
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Stroke
Interventions: High intensity gait training in a balance challenging Movement amplification environment; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke, Large Vessel Occlusion
Interventions: Mechanical thrombectomy via blood flow reversal using BOBBY balloon guide catheter; Device
Lead sponsor: MediSys Health Network; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Jamaica, New York

Conditions: Hypertension, Cardiovascular Risk Factor
Interventions: Forced Desynchrony; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 30 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cosmetic Techniques
Interventions: Restylane-L®, Restylane-L® Lyft, Restylane Silk®; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Atrial Fibrillation
Interventions: Idrabiotaparinux sodium, Warfarin, Placebo (for idrabiotaparinux), Placebo (for warfarin), Avidin, Placebo (for avidin); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 3,773 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 162
States / cities: Mobile, Alabama • Tucson, Arizona • Little Rock, Arkansas + 134 more

Conditions: Breast Neoplasm Female, Arthralgia, Aging
Interventions: Aromatase inhibitor; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Homocystinuria
Interventions: Pegtibatinase; Drug
Lead sponsor: Travere Therapeutics, Inc.; Industry
Eligibility: 5 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 13
States / cities: Phoenix, Arizona • New Haven, Connecticut • Atlanta, Georgia + 10 more

Conditions: Pseudomonas Infection
Interventions: Ciprofloxacin (Cipro, BAYQ3939); Drug
Lead sponsor: Bayer; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 4
States / cities: Atlanta, Georgia • Baltimore, Maryland • Boston, Massachusetts + 1 more

Conditions: Alzheimer Disease
Interventions: PI-2620 tracer for Tau PET scan; Diagnostic Test
Lead sponsor: University of North Texas Health Science Center; Other
Eligibility: 50 Years and older
Enrollment: 3,000 participants
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Pregnancy, Preterm Labor, Maternal Fetal Factors, Preterm Birth
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 746 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pregnancy Related, Adolescent Behavior, Sexually Transmitted Diseases
Interventions: Next4You; Behavioral
Lead sponsor: ETR Associates; Other
Eligibility: 16 Years to 19 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Colon Cancer
Interventions: Not listed
Lead sponsor: Texas A&M University; Other
Eligibility: 50 Years to 75 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Herpes Zoster
Interventions: Herpes zoster vaccine (GSK 1437173A), Placebo; Biological · Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 568 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 8
States / cities: Inverness, Florida • Chicago, Illinois • Elkhart, Indiana + 5 more

Conditions: Chlorhexidine Allergy, Infection, Rash
Interventions: Chlorhexidine gluconate; Drug
Lead sponsor: Celeste Chandonnet; Other
Eligibility: 36 Weeks to 48 Weeks
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Post Surgical Respiratory Failure, Respiratory Complication, Opioid Induced Respiratory Depression, Respiratory Arrest
Interventions: Linshom Continuous Predictive Respiratory Monitoring; Device
Lead sponsor: Linshom Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 394 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland • Columbus, Ohio

Search by objective public record fields.

Exercise Capacity in Pediatric Sickle Cell Anemia

Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents

Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients

Combined Effects of Prolonged Sitting and Mental Stress on the Cardiovascular System

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Study of Human Sensory Perception

Enhancing Brain And Mental Health Through Breathing Practice

Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance

Walking Balance Training Post-Stroke

Mechanical Thrombectomy Blood Flow Reversal

Sleep and Circadian Mechanisms of Non-dipping Blood Pressure

Prospective Evaluation of Facial Cosmetic Procedures

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging

A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE)

Cipro Inhaler for Cystic Fibrosis Children Ages 6-12

Health and Aging Brain Study: Health Disparities Tau Positron Emission Tomography (PET) Scan Study

Biomarkers in Obstetrical Complications

Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care

Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients

Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers

Pilot Study: Safety of Chlorhexidine (CHG) Baths in Patients Less Than 2 Months of Age

Clinical Evaluation of an Alarm Activated Detection System to Enable Early Intervention of Emerging Respiratory Decline With the Linshom Medical Continuous Predictive Respiratory Sensor (CPRS)